Side effects associated with pneumococcal vaccination

American Journal of Infection Control

Volumn 25, Issue 3, 1997, Pages 223-228

  Nichol, K L ^a   Mac Donald, R ^a   Hauge, M ^a  

^a VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADULT; AGED; ARTICLE; DISEASE COURSE; DISEASE DURATION; FATIGUE; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALAISE; MALE; MYALGIA; RASH; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 0030990687     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-6553(97)90008-0     Document Type: Article

References (27)

1. Centers for Disease Control and Prevention. ACIP - update: pneumococcal polysaccharide vaccine usage - United States. MMWR 1984;33:273-81.
2. Breiman RF, Spika JS, Navarro VJ, et al. Pneumococcal bacteremia in Charleston County, South Carolina: a decade later. Arch Intern Med 1990;150:1401-5.
3. Felice GA, Darby CP, Fraser DW. Pneumococcal bacteremia in Charleston County, South Carolina. Am J Epidemiol 1980;112:828-35.
4. Mufson MA, Oley G, Hughey D. Pneumococcal disease in a medium-sized community in the United States. JAMA 1982;248:1486-9.
5. Bennett NM, Buffington J, LaForce FM. Pneumococcal bacteremia in Monroe County, New York. Am J Public Health 1992;82:1513-6.
6. Centers for Disease Control and Prevention. Pneumonia and influenza death rates - United States, 1979-1994. MMWR 1995;44:535-7.
7. Breiman RF, Butler JC, Tenover FC, et al. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 1994;271:1831-5.
8. Immunization Practices Advisory Committee. Pneumococcal polysaccharide vaccine. MMWR 1989;38:64-76.
9. American College of Physicians and Infectious Diseases Society of America. Guide for adult immunization. 3rd ed. Philadelphia: American College of Physicians; 1994.
10. U.S. Preventive Services Task Force. Guide to clinical preventive services. Baltimore: Williams & Wilkins; 1989.
11. Public Health Service. Healthy people 2000: national health promotion and disease prevention objectives. Washington, DC: U.S. Department of Health and Human Services, Public Health Service; 1991. DHHS publication no. (PHS) 91-50213.
12. Centers for Disease Control and Prevention. Influenza and pneumococcal vaccination coverage levels among persons aged 63 ≥ 65 years - United States, 1973-1993. MMWR 1995;44:506-7, 513-5.
13. Centers for Disease Control and Prevention. Assessing adult vaccination status at age 50 years. MMWR 1995; 44:561-3.
14. Riddiough MA, Willems JS, Sanders CR, Kemp K. Factors affecting the use of vaccines: considerations for immunization program planners. Public Health Rep 1981;96:528-35.
15. Centers for Disease Control and Prevention. Adult immunization: knowledge, attitudes, and practices - DeKalb and Fulton counties, Georgia, 1988. MMWR 1988;37:657-61.
16. Rushton TC, Ganguly R, Sinnott JT, Banerji M. Barriers to immunization - an examination of factors that influence the application of pneumococcal vaccine by house staff. Vaccine 1994;12:1173-9.
17. Williams WW. Hawaii pneumococcal disease initiative: surveys of consumer and physician knowledge, attitudes, and practices. Proceedings of the 26th National Immunization Conference; 1992 June 1-6; St Louis.
18. Nichol KL. Long-term success with the national health objective for influenza vaccination: an institution-wide model. J Gen Intern Med 1992;7:595-600.
19. Margolis KX, Nichol KL, Poland GA, et al. Frequency of adverse reactions to influenza vaccine in the elderly: a randomized, placebo-controlled trial. JAMA 1990;264:1139-41.
20. Nichol KL, Margolis KL, Lind A, et al. Side effects following influenza vaccination in healthy working adults. Arch Intern Med In press.
21. Schwartz JS. Pneumococcal vaccine: clinical efficacy and effectiveness. Ann Intern Med 1982;96:208-20.
22. Austrian R. Pneumococcal infection and pneumococcal vaccine. N Engl J Med 1977;297:938-9.
23. Weibel RE, Vella PP, McLean AA, et al. Studies in human subjects of polyvalent pneumococcal vaccines (39894). Proc Soc Exp Biol Med 1977;156:144-50.
24. Carlson AJ, Davidson WL, McLean AA, et al. Pneumococcal vaccine: dose, revaccination, and coadministration with influenza vaccine (40596). Proc Soc Exp Biol Med 1979;161:558-63.
25. Hilleman MR, Carlson AJ, McLean AA, et al. Streptococcus pneumoniae polysaccharide vaccine: age and dose responses, safety, persistence of antibody, revaccination, and simultaneous administration of pneumococcal and influenza vaccines. Rev Infect Dis 1981;3(suppl):S31-S42.
26. DeStefano F, Goodman RA, Noble GR, et al. Simultaneous administration of influenza and pneumococcal vaccines. JAMA 1982;247:2551-4.
27. Rodriguez R, Dyer PD. Safety of pneumococcal revaccination. J Gen Intern Med 1995;10:511-2